Ligand validation:3H0C

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3H0C designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
3H0C_NAG_A_796	100%	58%	0.02	0.995	0.47	1.12	-	1	0	0	100%	0.9333
3H0C_NAG_B_794	100%	54%	0.024	0.994	0.51	1.24	-	3	0	0	100%	0.9333
3H0C_NAG_B_796	100%	61%	0.024	0.991	0.49	0.99	-	1	0	0	100%	0.9333
3H0C_NAG_A_793	100%	57%	0.029	0.987	0.51	1.11	-	1	0	0	100%	0.9333
3H0C_NAG_B_793	100%	44%	0.03	0.986	0.61	1.51	-	2	0	0	100%	0.9333
3H0C_NAG_A_795	100%	54%	0.029	0.984	0.52	1.23	-	2	0	1	100%	0.9333
3H0C_NAG_B_797	100%	64%	0.031	0.983	0.57	0.81	-	1	0	1	100%	0.9333
3NOX_NAG_A_851	94%	61%	0.07	0.971	0.58	0.91	-	-	0	0	100%	0.9333
3SWW_NAG_A_851	89%	58%	0.082	0.962	0.65	0.94	-	-	0	0	100%	0.9333
3OC0_NAG_A_794	89%	35%	0.076	0.953	0.76	1.76	-	6	0	0	100%	0.9333
4N8E_NAG_B_804	87%	63%	0.073	0.944	0.29	1.12	-	3	0	0	100%	0.9333
4N8D_NAG_A_811	84%	75%	0.076	0.938	0.42	0.54	-	-	2	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.